Director of Brain Health, McKinsey Health Institute, Washington D.C.
Kana Enomoto
eMHIC Special Interest Group on Strategy and Policy
Kana Enomoto, Director of Brain Health for the McKinsey Health Institute, is a nationally recognized expert in mental health, substance use, social determinants, and trauma. Kana advises the full gamut of public and private sector healthcare stakeholders on reducing the burden of mental illnesses and substance use disorders in the US and beyond. Prior to joining McKinsey, Kana was a member of the federal Senior Executive Service, where she advised the White House and the Surgeon General while leading SAMHSA, the $10B federal agency responsible for US mental health and substance use policy, data, and programs.
Dr Nina Ferencic
Senior Regional Adviser on Adolescent Health, Development and Participation, UNICEF
Prof. Andrew Greenshaw
Professor of Psychiatry and Neuroscience University of Alberta, Canada
Niki Legge
Director of Mental Health and Addictions, Government of Canada, Newfoundland and Labrador, Canada
Dr Judith Kuriansky
Professor of Psychology and Education, Columbia University Teachers College; Advisor, Mission of Sierra Leone to the United Nations
Fran Silvestri
Former President and CEO, International Initiative for Mental Health Leadership (IIMHL)
Mary O'Hagan
Executive Director Lived Experience, Department of Health, Victoria, Australia
Dr Bruce Arroll
Professor of General Practice and Primary Health Care, University of Auckland, New Zealand
Professor Chee Ng
Professor and Healthscope Chair of Psychiatry, The Melbourne Clinic, Australia
Lucita Lazo
President of the World Association for Psychosocial Rehabilitation, Philippines
Join the discussion
Don't forget to join a discussion forum on your topic of interest!
